AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1124.0014.2 (+1.28 %)
PREV CLOSE ( ) 1109.80
OPEN PRICE ( ) 1111.85
BID PRICE (QTY) 1123.60 (2)
OFFER PRICE (QTY) 1124.35 (2)
VOLUME 66736
TODAY'S LOW / HIGH ( )1095.70 1124.00
52 WK LOW / HIGH ( )556.2 1177
NSE1121.2510.15 (+0.91 %)
PREV CLOSE( ) 1111.10
OPEN PRICE ( ) 1113.85
BID PRICE (QTY) 1121.45 (18)
OFFER PRICE (QTY) 1121.75 (13)
VOLUME 1109955
TODAY'S LOW / HIGH( ) 1095.80 1124.20
52 WK LOW / HIGH ( )556.1 1177.1
Managing DirectorK Nithyananda Reddy
Company SecretaryB Adi Reddy
Promoter & Non-Executive DirectorPV Ramprasad Reddy
Independent DirectorDeepali Pant Joshi
Non Executive Independent DirectorSavita Mahajan
Girish Vanvari
Santanu Mukherjee
Satakarni Makkapati
Whole Time DirectorM Madan Mohan Reddy
Non Independent & Non Executive DirectorP Sarath Chandra Reddy
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet Hyderabad,
Telangana-500038 .

Phone 040-23736370 / 23747340

Email  info@aurobindo.com 

Industry Pharmaceuticals & Drugs

Listing BSE,NSE,MCX

Incorporation Year : 26-12 1986
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.